A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer
Authors
Keywords
Triple negative breast cancer, Nanocarriers, Gene therapy, Phytochemicals, Tumor targeting
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 330, Issue -, Pages 72-100
Publisher
Elsevier BV
Online
2020-12-14
DOI
10.1016/j.jconrel.2020.12.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer
- (2020) Danielle M. Valcourt et al. ACS Nano
- Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles
- (2020) Yiliang Yang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells
- (2020) Gamal-Eldein Fathy Abd-Ellatef et al. Pharmaceutics
- Investigating the Potential of Conjugated Selenium Redox Folic Acid as a Treatment for Triple Negative Breast Cancer
- (2020) Soni Khandelwal et al. Antioxidants
- CD44 receptor targeted ‘smart’ multi-walled carbon nanotubes for synergistic therapy of triple-negative breast cancer
- (2020) Nidhi Jain Singhai et al. Colloid and Interface Science Communications
- EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer
- (2020) Ankita Sanjay Burande et al. AAPS PHARMSCITECH
- The Landscape of Targeted Therapies in TNBC
- (2020) Elena Vagia et al. Cancers
- Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
- (2020) Anna Diana et al. Cancers
- Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model
- (2020) Noraini Nordin et al. MOLECULES
- Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition
- (2020) Jialong Fan et al. Acta Biomaterialia
- Activated Platelets-Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer
- (2019) Yujie Zhang et al. ADVANCED FUNCTIONAL MATERIALS
- Aptamer-functionalized liposomes for targeted cancer therapy
- (2019) Seyedeh Alia Moosavian et al. CANCER LETTERS
- Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides
- (2019) Anabel Sorolla et al. Nanomedicine-Nanotechnology Biology and Medicine
- Inhibition of Murine Breast Cancer Metastases by Hydrophilic As4S4 Nanoparticles Is Associated With Decreased ROS and HIF-1α Downregulation
- (2019) Tao Wang et al. Frontiers in Oncology
- Sphingosine-kinase-1 signaling promotes metastasis of triple-negative breast cancer
- (2019) Sunil Acharya et al. CANCER RESEARCH
- CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
- (2019) Ru Zhou et al. Frontiers in Immunology
- Hyaluronic acid-coated pH sensitive poly (β-amino Ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment
- (2019) Yingqi Xu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Curcumin induces DNA damage by mediating homologous recombination mechanism in triple negative breast cancer
- (2019) Gamze Guney Eskiler et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Enhancing Triple Negative Breast Cancer Immunotherapy by ICG‐Templated Self‐Assembly of Paclitaxel Nanoparticles
- (2019) Bing Feng et al. ADVANCED FUNCTIONAL MATERIALS
- Targeting Triple Negative Breast Cancer Cells with Novel Cytotoxic Peptide–Doxorubicin Conjugates
- (2019) Elmira Ziaei et al. BIOCONJUGATE CHEMISTRY
- Deguelin Impairs Cell Adhesion, Migration and Invasion of Human Lung Cancer Cells through the NF-κB Signaling Pathways
- (2018) Yung-Ting Hsiao et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- A review on the chemotherapeutic potential of fisetin: In vitro evidences
- (2018) Kiruthika Sundarraj et al. BIOMEDICINE & PHARMACOTHERAPY
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Anti-Trop2 antibody-conjugated bioreducible nanoparticles for targeted triple negative breast cancer therapy
- (2018) Soyoung Son et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer
- (2018) Shubhangi Mahajan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Carbon nanotubes in the delivery of anticancer herbal drugs
- (2018) Hardi Jogi et al. Nanomedicine
- CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer
- (2018) Satish Agrawal et al. Nanomedicine-Nanotechnology Biology and Medicine
- Carbon nanotubes (CNTs) based advanced dermal therapeutics: current trends and future potential
- (2018) Kaushik Kuche et al. Nanoscale
- Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands
- (2018) Jie Tang et al. Nanoscale
- Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer
- (2018) Rahul Jadia et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Gene therapy comes of age
- (2018) Cynthia E. Dunbar et al. SCIENCE
- Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
- (2018) Linda Xiaoyan Li et al. Cell Death & Disease
- Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment
- (2018) Supang Khondee et al. Current Drug Delivery
- SIRT1 promotes formation of breast cancer through modulating Akt activity
- (2018) Xiaoxia Jin et al. Journal of Cancer
- Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells
- (2018) Zahra Kayani et al. BIOMEDICINE & PHARMACOTHERAPY
- Pseudopterosin Inhibits Proliferation and 3D Invasion in Triple-Negative Breast Cancer by Agonizing Glucocorticoid Receptor Alpha
- (2018) Julia Sperlich et al. MOLECULES
- Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer
- (2018) Gamze Guney Eskiler et al. PHARMACEUTICAL RESEARCH
- ICAM1 expression is induced by proinflammatory cytokines and associated with TLS formation in aggressive breast cancer subtypes
- (2018) Stine L. Figenschau et al. Scientific Reports
- Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer
- (2018) Khaled Greish et al. JOURNAL OF CONTROLLED RELEASE
- Magnetically Guided Self-Assembled Protein Micelles for Enhanced Delivery of Dasatinib to Human Triple-Negative Breast Cancer Cells
- (2018) Sally A. Sabra et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The clinical promise of immunotherapy in triple-negative breast cancer
- (2018) Praveen Vikas et al. Cancer Management and Research
- Folic acid conjugated curcumin loaded biopolymeric gum acacia microsphere for triple negative breast cancer therapy in invitro and invivo model
- (2018) Kunal Pal et al. Materials Science & Engineering C-Materials for Biological Applications
- Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer
- (2018) Mengru Wang et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- STAT3 activation by leptin receptor is essential for TNBC stem cell maintenance
- (2017) Praveena S Thiagarajan et al. ENDOCRINE-RELATED CANCER
- Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles
- (2017) Marco C. Cavaco et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Styrene maleic acid-encapsulated RL71 micelles suppress tumor growth in a murine xenograft model of triple negative breast cancer
- (2017) Orleans Martey et al. International Journal of Nanomedicine
- αvβ3 integrin-targeted micellar mertansine prodrug effectively inhibits triple-negative breast cancer in vivo
- (2017) Ping Zhong et al. International Journal of Nanomedicine
- Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
- (2017) Ping-Hsiu Wu et al. International Journal of Nanomedicine
- iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
- (2017) Fei Gao et al. International Journal of Nanomedicine
- Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells
- (2017) Jaleh Varshosaz et al. JOURNAL OF LIPOSOME RESEARCH
- Functionalized Lipid–Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes
- (2017) Neeraj K. Garg et al. MOLECULAR PHARMACEUTICS
- Modified gold-based siRNA nanotherapeutics for targeted therapy of triple-negative breast cancer
- (2017) Reza Shahbazi et al. Nanomedicine
- Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies
- (2017) Heba E. Elsayed et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate
- (2017) Lorenzo Depau et al. Oncotarget
- Aptamer-mediated impairment of EGFR-integrin αvβ3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers
- (2017) Simona Camorani et al. Scientific Reports
- RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies
- (2017) Venkata Talluri Siddhartha et al. Artificial Cells Nanomedicine and Biotechnology
- Phospholipid-mimic oxaliplatin prodrug liposome for treatment of the metastatic triple negative breast cancer
- (2017) Bing Feng et al. Biomaterials Science
- Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer
- (2017) Li Zhang et al. Scientific Reports
- H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer
- (2017) S. Mazzucchelli et al. Scientific Reports
- Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology
- (2016) Gui-Hong Chai et al. ACS Applied Materials & Interfaces
- Hyaluronan: A modulator of the tumor microenvironment
- (2016) Theerawut Chanmee et al. CANCER LETTERS
- Nab-paclitaxel for the treatment of triple-negative breast cancer: Rationale, clinical data and future perspectives
- (2016) Francesco Schettini et al. CANCER TREATMENT REVIEWS
- Development and characterization of bilayer films of FucoPol and chitosan
- (2016) Ana R.V. Ferreira et al. CARBOHYDRATE POLYMERS
- Novel diindolylmethane derivatives based NLC formulations to improve the oral bioavailability and anticancer effects in triple negative breast cancer
- (2016) Chandraiah Godugu et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome
- (2016) Rhiannon K Beckers et al. HISTOPATHOLOGY
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy
- (2016) Mei-Xia Zhao et al. Nanoscale Research Letters
- Biology and Management of Patients With Triple-Negative Breast Cancer
- (2016) P. Sharma ONCOLOGIST
- Novel targets for paclitaxel nano formulations: Hopes and hypes in triple negative breast cancer
- (2016) Anita K. Bakrania et al. PHARMACOLOGICAL RESEARCH
- Dual Action Enhancement of Gold Nanoparticle Radiosensitization by Pentamidine in Triple Negative Breast Cancer
- (2016) Sohyoung Her et al. RADIATION RESEARCH
- Activation of proto-oncogenes by disruption of chromosome neighborhoods
- (2016) D. Hnisz et al. SCIENCE
- Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain
- (2016) Xu Wan et al. Oncotarget
- Aptamers: A promising chemical antibody for cancer therapy
- (2016) Gang Zhou et al. Oncotarget
- The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer
- (2016) Yubing Zhou et al. Oncotarget
- SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer
- (2016) Anjie Zhu et al. Oncotarget
- FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
- (2016) Zuhal Hamurcu et al. Oncotarget
- ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
- (2016) Peng Guo et al. Theranostics
- The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy
- (2016) Mei-Xia Zhao et al. Nanoscale Research Letters
- Targeted Mesoporous Silica Nanoparticles Delivering Arsenic Trioxide with Environment Sensitive Drug Release for Effective Treatment of Triple Negative Breast Cancer
- (2016) Xiaohui Wu et al. ACS Biomaterials-Science & Engineering
- Targeted Mesoporous Silica Nanoparticles Delivering Arsenic Trioxide with Environment Sensitive Drug Release for Effective Treatment of Triple Negative Breast Cancer
- (2016) Xiaohui Wu et al. ACS Biomaterials Science & Engineering
- Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer
- (2016) Hitesh Kulhari et al. Scientific Reports
- Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
- (2015) Dan Shu et al. ACS Nano
- “Triple-Punch” Strategy for Triple Negative Breast Cancer Therapy with Minimized Drug Dosage and Improved Antitumor Efficacy
- (2015) Shishuai Su et al. ACS Nano
- Polymer Nanoparticles Mediated Codelivery of AntimiR-10b and AntimiR-21 for Achieving Triple Negative Breast Cancer Therapy
- (2015) Rammohan Devulapally et al. ACS Nano
- Combination of microRNA therapeutics with small-molecule anticancer drugs: Mechanism of action and co-delivery nanocarriers
- (2015) Xin Dai et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting thyroid hormone receptor beta in triple-negative breast cancer
- (2015) Guowei Gu et al. BREAST CANCER RESEARCH AND TREATMENT
- Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer
- (2015) Shuang Li et al. CANCER BIOLOGY & THERAPY
- Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: In-vitro optimization and in-vivo performance in humans
- (2015) Samar M. Abouelatta et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Phytochemicals potently inhibit migration of metastatic breast cancer cells
- (2015) Stephanie Lemmo Ham et al. Integrative Biology
- Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment
- (2015) Vivek K. Pawar et al. Journal of Biomedical Nanotechnology
- Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy
- (2015) Song Shen et al. JOURNAL OF CONTROLLED RELEASE
- One-component nanomedicine
- (2015) Hao Su et al. JOURNAL OF CONTROLLED RELEASE
- Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells
- (2015) A. Gilboa-Geffen et al. MOLECULAR CANCER THERAPEUTICS
- Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer
- (2015) R. Paulmurugan et al. MOLECULAR CANCER THERAPEUTICS
- Glycan-related gene expression signatures in breast cancer subtypes; relation to survival
- (2015) Ivan O. Potapenko et al. Molecular Oncology
- Anti-migratory and increased cytotoxic effects of novel dual drug-loaded complex hybrid micelles in triple negative breast cancer cells
- (2015) Rajaletchumy Veloo Kutty et al. Nano Research
- Physicochemical behavior of nanohybrids of mono and tetra substituted carboxyphenoxy phthalocyanine covalently linked to GSH–CdTe/CdS/ZnS quantum dots
- (2015) David O. Oluwole et al. POLYHEDRON
- Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease
- (2015) Murugan Kalimutho et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer
- (2015) Zhong Chen et al. Nature Communications
- The role of taxanes in triple-negative breast cancer: literature review
- (2015) Giorgio Mustacchi et al. Drug Design Development and Therapy
- Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)*
- (2015) David M. Goldenberg et al. Oncotarget
- Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment
- (2015) Guanlian Hu et al. Oncotarget
- Small Sized EGFR1 and HER2 Specific Bifunctional Antibody for Targeted Cancer Therapy
- (2015) Li Ding et al. Theranostics
- RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
- (2015) James Finlay et al. Biomed Research International
- siRNA Versus miRNA as Therapeutics for Gene Silencing
- (2015) Jenny K W Lam et al. Molecular Therapy-Nucleic Acids
- Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer
- (2015) Suniti Misra et al. Frontiers in Immunology
- Non-Specific Blocking of miR-17-5p Guide Strand in Triple Negative Breast Cancer Cells by Amplifying Passenger Strand Activity
- (2015) Yuan-Yuan Jin et al. PLoS One
- Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs
- (2014) Katja Čerpnjak et al. ACTA PHARMACEUTICA
- PEG-detachable lipid–polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells
- (2014) Jiang-bo Du et al. ANTI-CANCER DRUGS
- Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells
- (2014) M Mancini et al. BRITISH JOURNAL OF CANCER
- Mechanisms of Hypoxia-Mediated Immune Escape in Cancer
- (2014) I. B. Barsoum et al. CANCER RESEARCH
- Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy
- (2014) Jiacheng Zhao et al. CHEMICAL COMMUNICATIONS
- Recent developments in biological activities of chalcones: A mini review
- (2014) Parvesh Singh et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
- (2014) Yan Deng et al. GENE
- The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling
- (2014) Marie-Kristin von Wahlde et al. GYNECOLOGICAL ENDOCRINOLOGY
- Triple-negative breast cancer: An institutional analysis
- (2014) V Raina et al. INDIAN JOURNAL OF CANCER
- MicroRNA 21 (miR-21) and miR-181b Couple with NFI-A To Generate Myeloid-Derived Suppressor Cells and Promote Immunosuppression in Late Sepsis
- (2014) Clara McClure et al. INFECTION AND IMMUNITY
- Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells
- (2014) Michela Bellini et al. JOURNAL OF CONTROLLED RELEASE
- Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium
- (2014) Erik O. Pettersen et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy
- (2014) Stephanie Tortorella et al. JOURNAL OF MEMBRANE BIOLOGY
- MTBP Is Overexpressed in Triple-Negative Breast Cancer and Contributes to Its Growth and Survival
- (2014) B. C. Grieb et al. MOLECULAR CANCER RESEARCH
- ICAM-1 as a molecular target for triple negative breast cancer
- (2014) P. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic potential of siRNA and DNAzymes in cancer
- (2014) Hanuma Kumar Karnati et al. TUMOR BIOLOGY
- Self-assembled targeting of cancer cells by iron(iii)-doped, silica nanoparticles
- (2014) K. K. Pohaku Mitchell et al. Journal of Materials Chemistry B
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
- (2014) Pedro M. D. Moreno et al. Frontiers in Chemistry
- Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
- (2013) Zhou J. Deng et al. ACS Nano
- Androgen Receptor-Positive Triple Negative Breast Cancer: A Unique Breast Cancer Subtype
- (2013) Lee J. McGhan et al. ANNALS OF SURGICAL ONCOLOGY
- Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system
- (2013) Golam Kibria et al. ARCHIVES OF PHARMACAL RESEARCH
- Application of Aptamers for Targeted Therapeutics
- (2013) Partha Ray et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers
- (2013) Rajaletchumy Veloo Kutty et al. BIOMATERIALS
- Oncolytic adenovirus encoding tumor necrosis factor-related apoptosis inducing ligand (TRAIL) inhibits the growth and metastasis of triple-negative breast cancer
- (2013) Wei Zhu et al. CANCER BIOLOGY & THERAPY
- A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells
- (2013) Fabio Petrocca et al. CANCER CELL
- The relevance of the TGF-β Paradox to EMT-MET programs
- (2013) Chevaun D. Morrison et al. CANCER LETTERS
- microRNAs in breast cancer development and treatment
- (2013) Danila Serpico et al. CANCER TREATMENT REVIEWS
- Maleimide-functionalised platinum(iv) complexes as a synthetic platform for targeted drug delivery
- (2013) Verena Pichler et al. CHEMICAL COMMUNICATIONS
- Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy
- (2013) Vasudevanpillai Biju CHEMICAL SOCIETY REVIEWS
- Glucocorticoid Receptor Antagonism as a Novel Therapy for Triple-Negative Breast Cancer
- (2013) M. N. Skor et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
- (2013) Kunn Hadinoto et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules
- (2013) Fardin Tamjidi et al. Innovative Food Science & Emerging Technologies
- Anticancer Activity of Small-Molecule and Nanoparticulate Arsenic(III) Complexes
- (2013) Elden P. Swindell et al. INORGANIC CHEMISTRY
- Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer
- (2013) P. Heldin et al. JOURNAL OF BIOCHEMISTRY
- Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β
- (2013) Jenny G. Parvani et al. MOLECULAR BIOLOGY OF THE CELL
- Structural basis for molecular recognition of folic acid by folate receptors
- (2013) Chen Chen et al. NATURE
- Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells
- (2013) Rajeshwari Mehta et al. PLoS One
- Epithelial-mesenchymal transition and its regulators are major targets of triple-negative breast cancer
- (2013) Ala-Eddin Al Moustafa Cell Adhesion & Migration
- Nanocarriers for Diagnosis and Targeting of Breast Cancer
- (2013) Arun Sharma et al. Biomed Research International
- A pH-Sensitive, Biobased Calcium Carbonate Aragonite Nanocrystal as a Novel Anticancer Delivery System
- (2013) Abdullahi Shafiu Kamba et al. Biomed Research International
- Vascular Permeability and Drug Delivery in Cancers
- (2013) Sandy Azzi et al. Frontiers in Oncology
- Design of polymeric nanoparticles for biomedical delivery applications
- (2012) Mahmoud Elsabahy et al. CHEMICAL SOCIETY REVIEWS
- Twist Confers Chemoresistance to Anthracyclines in Bladder Cancer through Upregulating P-Glycoprotein
- (2012) Yule Chen et al. CHEMOTHERAPY
- Time to put an end to the “one size fits all” approach to bisphosphonate use in patients with metastatic breast cancer?
- (2012) I. Kuchuk et al. Current Oncology
- Genistein inhibits MDA-MB-231 triple-negative breast cancer cell growth by inhibiting NF-κB activity via the Notch-1 pathway
- (2012) HONG PAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway
- (2012) S. Martins et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Piperine, a dietary phytochemical, inhibits angiogenesis
- (2012) Carolyn D. Doucette et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Androgen receptor in triple negative breast cancer
- (2012) K.M. McNamara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- PEGylated Liposomal Doxorubicin Targeted to α5β1-Expressing MDA-MB-231 Breast Cancer Cells
- (2012) Kamlesh Shroff et al. LANGMUIR
- Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
- (2012) Kelong Fan et al. Nature Nanotechnology
- Novel strategies targeting cancer stem cells through phytochemicals and their analogs
- (2012) Prasad Dandawate et al. Drug Delivery and Translational Research
- Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease
- (2012) Daniel J O’Shannessy et al. SpringerPlus
- Nanoparticle Delivery of Cancer Drugs
- (2011) Andrew Z. Wang et al. Annual Review of Medicine
- Thyroid hormone differentially modulates Warburg phenotype in breast cancer cells
- (2011) Sonal Suhane et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The transferrin receptor and the targeted delivery of therapeutic agents against cancer
- (2011) Tracy R. Daniels et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery
- (2011) Hye Yeong Nam et al. BIOMATERIALS
- Lipocalin 2: A multifaceted modulator of human cancer
- (2011) Jiang Yang et al. CELL CYCLE
- Enhanced Metastasis Suppression by Targeting TRAIL Receptor 2 in a Murine Model of Triple-Negative Breast Cancer
- (2011) D. Malin et al. CLINICAL CANCER RESEARCH
- Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer
- (2011) Laszlo Otvos et al. EUROPEAN JOURNAL OF CANCER
- CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC Cells
- (2011) Ai–Wu Ke et al. GASTROENTEROLOGY
- Antibody-targeted nanoparticles for cancer therapy
- (2011) Francois Fay et al. Immunotherapy
- Src Regulates Tyr20Phosphorylation of Transferrin Receptor-1 and Potentiates Breast Cancer Cell Survival
- (2011) Jinlong Jian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
- (2011) Lifang Yang et al. MOLECULES
- Genetic therapies for RNA mis-splicing diseases
- (2011) Suzan M. Hammond et al. TRENDS IN GENETICS
- Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy
- (2011) Hiroshi Yagata et al. Breast Cancer
- MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer
- (2011) Maitri Y Shah et al. Genome Medicine
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Protein kinase CK2α subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarrays
- (2010) Sophie Giusiano et al. EUROPEAN JOURNAL OF CANCER
- Autophagy Induction by Capsaicin in Malignant Human Breast Cells Is Modulated by p38 and Extracellular Signal-Regulated Mitogen-Activated Protein Kinases and Retards Cell Death by Suppressing Endoplasmic Reticulum Stress-Mediated Apoptosis
- (2010) C.-H. Choi et al. MOLECULAR PHARMACOLOGY
- Click Chemistry for the Synthesis of RGD-Containing Integrin Ligands
- (2010) Matteo Colombo et al. MOLECULES
- A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis
- (2010) J Odvody et al. ONCOGENE
- Recent advances in large-scale production of monoclonal antibodies and related proteins
- (2010) Abhinav A. Shukla et al. TRENDS IN BIOTECHNOLOGY
- siRNA vs. shRNA: Similarities and differences
- (2009) Donald D. Rao et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groups
- (2009) Carolina Salvador-Morales et al. BIOMATERIALS
- Thyroid Hormone Receptor 1 Acts as a Potent Suppressor of Tumor Invasiveness and Metastasis
- (2009) O. Martinez-Iglesias et al. CANCER RESEARCH
- Targeted delivery of an anti-cancer agent via steroid coupled liposomes
- (2009) Pramod K. Mishra et al. DRUG DELIVERY
- In vitro assessment of liposomal neridronate on MDA-MB-231 human breast cancer cells
- (2009) Imène Chebbi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tetraspanin CD151 regulates RhoA activation and the dynamic stability of carcinoma cell-cell contacts
- (2009) J. L. Johnson et al. JOURNAL OF CELL SCIENCE
- siRNA, miRNA, and shRNA: in vivo Applications
- (2009) P.N. Pushparaj et al. JOURNAL OF DENTAL RESEARCH
- Synthesis and Biological Activity of a Novel Series of 6-Substituted Thieno[2,3-d]pyrimidine Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors over the Reduced Folate Carrier and Proton-Coupled Folate Transporter for Cellular Entry†
- (2009) Yijun Deng et al. JOURNAL OF MEDICINAL CHEMISTRY
- CD151 Regulates Tumorigenesis by Modulating the Communication between Tumor Cells and Endothelium
- (2009) R. Sadej et al. MOLECULAR CANCER RESEARCH
- SPARC: a matricellular regulator of tumorigenesis
- (2009) Shanna A. Arnold et al. Journal of Cell Communication and Signaling
- Ferritins: A family of molecules for iron storage, antioxidation and more
- (2008) Paolo Arosio et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
- (2008) Juliana M. Chan et al. BIOMATERIALS
- Deoxyribozymes: useful DNA catalysts in vitro and in vivo
- (2008) D. A. Baum et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Does Loss of CD151 Expression Promote the Metastasis of Hypoxic Colon Cancer Cells?
- (2008) G. L. Semenza CLINICAL CANCER RESEARCH
- MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
- (2008) Z Lu et al. ONCOGENE
- Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells
- (2007) H YUAN et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search